期刊文献+

宫颈病变组织Survivin的表达及其临床意义 被引量:2

Expression of Survivin protein in tissues of cervical squamous cell carcinomas and its clinical significance
原文传递
导出
摘要 目的:探讨Survivin在宫颈鳞状上皮细胞癌(CSCC)和宫颈上皮内瘤变(CIN)组织中的阳性表达及相关性。方法:用免疫组织化学(IHC)SP法检测92例CSCC及癌旁正常宫颈组织和40例CIN组织中Survivin的蛋白表达情况,并对数据进行统计分析。结果:CSCC组中Survivin阳性表达率为78.26%(72/92),CINⅠ、CINⅡ和CINⅢ组分别为26.67%(4/15)、64.28%(9/14)和72.72%(8/11);正常宫颈鳞状上皮组织Sur-vivin阳性表达率为2.17%(2/92)。宫颈鳞癌组、CINⅡ、CINⅢ组Survivin的阳性表达明显高于CINⅠ组及正常宫颈组织,P<0.01;CINⅠ与CINⅡ、CINⅢ组之间Sur-vivin表达差异有统计学意义,P<0.05;Sur-vivin的表达在各组均与年龄无关。结论:Survivin的阳性表达与宫颈癌的进展、组织学分级和临床分期有关,而与年龄无关。宫颈癌临床分期越晚、细胞分化程度越低,Sur-vivin的阳性表达率越高。 OBJECTIVE:To study the protein expression of Survivin in the tissues of cervical disease,and the changes and correlation between cervical squamous cell carcinomas(CSCC) and cervical intraepithelial neoplasia(CIN).METHODS: The protein expression of Survivin was examined by SP immunohistochemical stain(IHC) method in 92 tumors of CSCC,corresponding normal tissues and 40 CIN tissues,and the results were analyzed.RESULTS:The positive expression rates were 78.26%(72/92) in CSCC,and 26.67%(4/15),64.28%(9/14),72.72%(8/11) respectively in the CINⅠ,CINⅡ,CINⅢ groups.The positive expression rate was 2.17%(2/92) in corresponding normal tissues.The protein expressions of Survivin in CSCC,CINⅡ and CINⅢ were significantly higher than those in the CINⅠ group and the corresponding normal tissues(P0.01).The protein expression of CINⅠ was significantly lower than those in the CINⅡ and CINⅢ groups(P0.05).The Survivin expression was not correlated with age.CONCLUSION: The protein expression of Survivin is correlated with the progression of cervical cancer,histological graduation and clinical stages,but has no correlation with age.
出处 《中华肿瘤防治杂志》 CAS 2010年第23期1939-1941,1945,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 宫颈肿瘤 宫颈上皮内瘤样病变 免疫组织化学 cervix neoplasms cervical intraepithelial neoplasms immunohistochemistry
  • 相关文献

参考文献7

二级参考文献26

  • 1郑金锋,马淑芳,耿明,曹永成,刘莹.p16和p15及PCNA在子宫颈癌组织中的表达及临床病理意义[J].中华肿瘤防治杂志,2007,14(4):291-293. 被引量:15
  • 2官立丽,彭芝兰,牛晓宇.HPV16 E6小干扰RNA与宫颈癌细胞中E6 p53 p21关系的研究[J].中国实用妇科与产科杂志,2007,23(7):517-519. 被引量:4
  • 3Schell W M, Janicek M F, Mirhashemi R. Epidemiology and bi ology of cervical cancer[J]. Semin Surg Oneol, 1999, 16(3):203-211.
  • 4Miehael F, Elka A, David O, et al. Immunohistochemical localization of survivin in benign eerdcal mucosa, cervical dysplasia, and invasive squamous cell carcinoma[J]. Am J Clin Pathol, 2002,117(5) :738.
  • 5Kim H S, Shiraki K, Park S H. Expression of survivin in CIN and invasive squamous cell carcinoma ofuterine cervix[J]. Antieancer Research, 2002, 22 (2) :805.
  • 6Ambrosch P, Schlott T, Hitmes D, et al. P16 alterations and retinohlastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract[J]. Virchows Arch, 2001, 438(4): 343 349.
  • 7Ding L, Zou X J, Ao J E, et al. ELISA test to detect CDKN2A [p16(INK4a)] expression in exfoliative cells: a new screening tool for cervicalcancer[J]. MolDiagnTher, 2008, 12(6): 395-400.
  • 8Ozgul N, Cil A P, Bozdayi G. Staining characteristics of p16INK4A: is there a correlation with lesion grade or high-risk human papilloma virus positivity[J]. J Obstet Gynaecol Res,2008, 34(5):865-871.
  • 9Negn G, Egarter-Vigl E, kasal A, et al. p16^INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations[J]. Am J Surg Pathol, 2003, 27(2) : 187-193.
  • 10Tommasino M, Accardi R, Caldeira S, et al. The role of TP53 in cervicalcareinogenesis[J]. Hum Mutat, 2003, 21 (3): 307-312.

共引文献94

同被引文献20

  • 1Jacoba D Z,Gerard C,Van R. Cervical cancer: radiotherapy and hyperthermia[J].Int J Hyperthermia, 2006,22 (3) : 229-234.
  • 2Martine F,Ronald D W,Anca C,et al. Weekly systemic cisplatin plus loeoregional hyperthermia: An effective treatment for pa- tients with recurrent cervical carcinoma in a previously irradiated area[J]. Int J Hyperthermia,2007,23(5) :443-450.
  • 3Franckena M, Stalpers L J, Koper P C, et al. long-term improve- ment in treatment outcome after radiotherapy and hyperthermia in Ioeoregionallyadvanced cervix cancer: an update of the Dutch deep hyperthermia trial[J]. Int J Radiation Oncology Biol Phys, 2008,70(4) :1176-1182.
  • 4Ambrosini G, Adida C,Altieri D C, et al. A novel anti-apoptosis gene,Survivin,expressed in cancer and lymphoma[J]. Nat Met, 1997,3(8) :917-921.
  • 5Shin S, Sung B J, Cho Y S, et al. An anti-apoptotic protein hu- man survivin is a direct inhibitor of caspase-3 and -7[J].Bio- chemistry,2001,40(4) :1117-1123.
  • 6Wall N R, Beck F W, AI-Katib A M, et al. Treatment-induced ex- pression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line[J]. J Drug Target , 2001,9 (5) : 329- 339.
  • 7Yoshida H,Sum/T, Hyun Y,et al. Expression of surviving and ma- trix metalloproteinases in adenicaecinoma and squamous cell arcinoma of the uterine cervix[J]. Oncol Rep, 2003,10 (1) : 45-49.
  • 8Joseph L, Roti R. Cellular responses to hyperthermia (40- 46 C): Cell killing and molecular eventsEJ]. Int J Hyperther- mia, 2008,24(1) :3-15.
  • 9Manivel P,Muthukumaran J,Kannan M,et al. Insight into resi- dues involved in the structure and {unction of the breast cancer associated protein human gamma synuclein [J]. J Mol Model, 2011,17(2):251-263.
  • 10Wu K, Quan Z, Weng Z, et al. Expression of neuronal protein sy- nuclein gamma gene as a novel marker for breast cancer progno- sis[J]. Breat Cancer Ras Treat, 2007,101 (3) : 259 267.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部